ANUHPHR91.70

Anuh Pharma Limited

· Pharma & Health
₹ CrorePeersAHCLWANBURYZIMLABBAJAJHCARETHEMISMEDLINCOLNVALIANTLABSIGACHIMcap ₹919 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation8.711.4
+ Finance Costs0.60.5
+ Interest Income-1.4-0.6
+ Dividend Income-0.0-0.1
+ Fair Value (Gains) / Losses-4.05.7
+ Unrealised FX (Gain) / Loss0.32.9
+ Other Non-cash Items-1.0-0.4
+ Other — Cash Effects are Investing / Financing-2.9-8.5
Changes in Working Capital
+ Inventories0.9-73.3
+ Trade Receivables — Current-27.1-19.9
+ Other Financial Assets — Current0.1-0.2
+ Other Financial Assets — Non-current0.69.9
+ Other Current Assets-5.31.4
+ Trade Payables — Current17.724.0
+ Other Financial Liabilities — Current0.61.3
+ Other Current Liabilities-0.62.1
Cash from Operating Activities
Profit Before Tax (per I/S)61.054.271.1
+ Total Adjustments (incl. Working Capital)-12.8-44.0
Cash from Operations (pre-tax)48.210.2
+ Income Taxes Paid11.113.2
Cash from Operating Activities37.1-3.0
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)20.07.9
+ Disp of Fixed Assets-0.20.1
+ Sale of Investments (Equity / Debt)-1.225.1
+ Dividends Received — Investing0.00.1
+ Interest Received — Investing1.40.5
Cash from Investing Activities-19.917.8
Cash from Financing Activities
+ Proceeds from Borrowings8.50.0
+ Repayment of Borrowings0.010.5
+ Payment of Lease Liabilities0.30.4
+ Interest Paid0.50.5
+ Dividends Paid12.515.0
Cash from Financing Activities-4.9-26.3
Net Changes in Cash (pre-FX)12.4-11.5
Net Changes in Cash12.4-11.5
Reference Items
EBITDA60.961.775.1
EBITDA Margin %9.218.007.78
Free Cash Flow (CFO − Capex)17.2-10.9-10.9
Free Cash Flow to Equity-21.9
Free Cash Flow per Basic Share1.71-1.09-1.09
Cash Flow to Net Income0.78-0.07
Cash Paid for Taxes11.113.2
Cash Paid for Interest0.50.5
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.